Diurnal Group plc (DNL.L) | Stock Information | Vox Markets
Vox Markets
DNL:LN

Diurnal Group plc

DNL:LN

Overview

Company Profile

Diurnal Group plc is a European, UK-headquartered specialty pharmaceutical company dedicated to developing hormone therapeutics to aid lifelong treatment for rare and chronic endocrine conditions, including Congenital Adrenal Hyperplasia, Adrenal Insufficiency, Hypogonadism and Hypothyroidism.

Classification

Corporate